Drugs / gene-modified tumor cell vaccine therapy
gene-modified tumor cell vaccine therapy
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00002748 | Dec 1991 → Aug 2007 | neuroblastoma | St. Jude Children's Research Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gene-modified tumor cell vaccine therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002748 ↗ |
| Modality | Cell therapy | “Autologous or partially HLA-matched allogeneic neuroblastoma cells are transduced with a human gene for interleukin-2 production.” NCT00002748 ↗ |
| Route | Subcutaneous | “two weekly subcutaneous injections” NCT00002748 ↗ |